User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer

Primary tabs

Auprich, Marco Bjartell, Anders Chun, Felix K.-H. de la Taille, Alexandre Freedland, Stephen J. Tombal, Bertrand [UCL] van der Poel, Henk

Newly discovered biomarkers ideally should prove clinical usefulness, provide additional detection, staging, and prognosis information to improve individual risk assessment, and potentially permit targeted cancer therapy.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès restreint
Publication date 2011
Language Anglais
Journal information "European Urology" - Vol. 60, no. 5, p. 1045-1054 (2011)
Peer reviewed yes
Publisher Elsevier BV (Amsterdam)
issn 0302-2838
e-issn 1421-993X
Publication status Publié
Affiliations UCL - (SLuc) Service d'urologie
UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation
MESH Subject Antigens, Neoplasm - genetics, urine ; Biopsy ; Prognosis ; Prostatic Neoplasms - diagnosis, genetics, pathology, therapy, urine ; Risk Assessment ; Risk Factors ; Tumor Markers, Biological - genetics, urine ; Decision Support Techniques ; Early Detection of Cancer ; Evidence-Based Medicine ; Humans ; Male ; Neoplasm Staging ; Patient Selection ; Predictive Value of Tests
Keywords PCA3 ; Prostate biopsy ; Prostate cancer detection ; Staging ; Targeted therapy
Links
Bibliographic reference Auprich, Marco ; Bjartell, Anders ; Chun, Felix K.-H. ; de la Taille, Alexandre ; Freedland, Stephen J. ; et. al. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer. In: European Urology, Vol. 60, no. 5, p. 1045-1054 (2011)
Permanent URL http://hdl.handle.net/2078.1/110067